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Abstract 3-Hydroxypropionaldehyde (3-HPA) forms, to-
gether with HPA-hydrate and HPA-dimer, a dynamic,
multi-component system (HPA system) used in food
preservation, as a precursor for many modern chemicals
such as acrolein, acrylic acid, and 1,3-propanediol (1,3-
PDO), and for polymer production. 3-HPA can be
obtained both through traditional chemistry and bacterial
fermentation. To date, 3-HPA has been produced from
petrochemical resources as an intermediate in 1,3-PDO
production. In vivo, glycerol is converted in one enzy-
matic step into 3-HPA. The 3-HPA-producing Lactoba-
cillus reuteri is used as a probiotic in the health care of
humans and animals. The biotechnological production of
3-HPA from renewable resources is desirable both for use
of 3-HPA in foods and for the production of bulk
chemicals. The main challenge will be the efficient
production and recovery of pure 3-HPA.
Elucidation of the HPA system
The very first observation leading eventually to the
elucidation of the synthesis pathway of 3-hydroxypropio-
naldehyde (3-HPA) dates back to as early as 1741.
Geoffrey (1742) described that a new water-soluble syrup
was formed from fat after saponification. In 1779, Scheele
isolated the same syrup from a diverse array of substrates,
including almonds, linseed, rape oils, olive oil, butter and
lard. Because of its sweet taste he named it “Ölsüss” (see
Scheele 1931). About 40 years later, the French pioneer of
organic chemistry Chevreul noted that, after saponifica-
tion, the neutral fats were transformed into solid fatty acids
and the sweet component of Scheele. He renamed this
liquid, believed to be an alcohol, glycerine (Chevreul
1823; Matagrin 1925).
Chevreul’s discoveries had some very practical implica-
tions for everyday life. The removal of glycerol from the
raw material of candles both greatly increased their
hardness and illuminating power, and eliminated the
unpleasant odour of burning candles that resulted from
glycerol decomposition (Matagrin 1925). Brandes was the
first to describe this decomposition product and name it
acrolein, thus reflecting both its smell (acris) and
consistency (oleum), whereas Berzelius was the first to
identify it as an aldehyde (Berzelius 1839). Meanwhile, in
Liebig’s laboratory, Redtenbacher noted that acrolein was
formed by the combustion of fats, but not of fatty acids.
Furthermore, he suspected that glycerol could be the
source of acrolein. During the distillation of glycerol he
obtained acrolein, and confirmed that it is an aldehyde
since upon further oxidation it formed a new acid, which
he named acrylic acid. Thus, Redtenbacher established
that acrolein can be formed from glycerol through the loss
of four molecules of water (Redtenbacher 1843).
Some years later, Nef heated acrolein in the presence of
water, which resulted in the formation of hydracrylalde-
hyde, or 3-HPA (Fig. 1); this was the first formal
description of the compound (Nef 1904). The kinetics of
acrolein hydration and the formation of 3-HPA were
studied later (Pressman and Lucas 1942). Redtenbacher
established that not only chemical, but also biological
reactions could use glycerol as a “substrate”, he described
the formation of propionic acid from glycerol by bacterial
fermentation (Redtenbacher 1846), and Pasteur discovered
that glycerol could also be formed during alcoholic
fermentation (Pasteur 1858a, 1858b). A few years later,
Napoleon asked Pasteur to study the origin of different
types of wine spoilage, referred to as “les maladies de
l’amertume des vins”. During this period, France produced
about 50 million hectolitres of wine worth about
500 million Francs annually, thus making the wine
industry the most profitable economic sector in France.
Considerable losses from different plant diseases, as well
as from wine spoilage itself, prompted this research.
S. Vollenweider (*) . C. Lacroix
Laboratory of Food Biotechnology, Institute of Food Science





Pasteur found that bacteria were responsible for the
formation of bitter tastes in wine leading to its spoilage
(Pasteur 1866).
However, only after 1910 was the connection made
between the formation of acrolein from glycerol by
bacterial fermentation and the spoilage of wine (Voisenet
1910). Moreover, Voisenet found that propanolal, now
referred to as 3-HPA, is formed as an intermediate in this
synthesis pathway (Fig. 1). He also identified trimethylene
glycol [1,3-propanediol (1,3-PDO)] as another product of
this fermentation process (Voisenet 1910, 1914a, 1914b)
(Fig. 1). Although Voisenet could identify the presence of
acrolein and 3-HPA by a colorimetric test, it was only in
1945 that a quantitative test using tryptophan was
developed for acrolein (Circle et al. 1945). The same
test was later used to determine the concentration of 3-
HPA.
In 1950, during the first systematic study of 3-HPA by
Hall and Stern, the importance of 3-HPA as an interme-
diate of great potential value in the solvent or plasticiser
field was mentioned. In their work, Hall and Stern
described a dimeric form of 3-HPA in equilibrium with
the monomeric form commonly found in solution (Hall
and Stern 1950). Finally in 1981, using NMR, Nielsen et
al. were able to identify HPA-hydrate as the last compo-
nent of the HPA system. In summary, the work of over
100 years of research outlined above has resulted in the
formulation of a complex reaction model in which 3-HPA
plays a central role (Fig. 1). In vivo, 3-HPA is produced by
dehydration of glycerol by a B12-dependent glycerol
dehydratase, and further reduced to 1,3-PDO by an
NAD+-dependent oxidoreductase (Toraya 2000). In aque-
ous solution, 3-HPA undergoes reversible dimerisation and
hydration, thus resulting in an equilibrium of 3-HPA,
HPA-hydrate, and HPA-dimer, referred to here as HPA or
the HPA-system. During thermal dehydration, acrolein is
formed in HPA-containing solutions (Fig. 1). Detailed
descriptions for the enzymatic pathway are given by Biebl
et al. (1999) and Lüthi-Peng et al. (2002a), and a detailed
description of acrolein formation is given by Hall and
Stern (1950) and Nielsen et al. (1981).
As illustrated by this historical outline, many compo-
nents of the HPA system can be obtained both through
traditional chemistry and bacterial fermentation (Mick-
elson and Werkman 1940; Otsuka 2003; Sobolov and
Smiley 1960). The current use and future prospects of the
HPA system in modern biotechnology, in particular as an
alternative to its production from fossil resources by the
petrochemical industry, will be discussed below.
Production of 3-HPA
Petrochemically derived 3-HPA
The raw materials for the multistep synthesis are obtained
from the petrochemical industry. Two chemical processes
are known to produce 3-HPA as an intermediate in 1,3-
PDO production: the Degussa and Shell processes. The
Degussa process begins with the catalytic transformation
of propylene into acrolein, which is hydrated to 3-HPA
and further reduced to 1,3-PDO (Arntz and Wiegand 1991;
Brossmer and Arntz 2000). Although propylene is
inexpensive, the separation of the different molecules is
expensive and acrolein is toxic. The 1,3-PDO yield of this
process is only 43%. The Shell process begins with
ethylene, forming ethylene oxide, which is transformed by
a hydroformylation reaction under high pressure (150 bar)
with syngas to 3-HPA (Knifton et al. 2003). Ethylene is
inexpensive and the intermediate products are not toxic,
but 3-HPA has to be extracted from the organic phase. The
1,3-PDO yield is about 80%. No information on the yields
for 3-HPA production is available in the literature.
3-HPA from renewable resources
Biotechnological production has several advantages com-
pared to the chemical process. First, 3-HPA production can
be carried out in glycerol-containing aqueous solution at
room temperature or at 37°C under normal pressure. The
transformation from glycerol to 3-HPA is a one-step
enzymatic catalysis (Fig. 1) and the yields (85–87% mol 3-
HPA/mol glycerol) have been shown to be higher than
those achieved by chemical synthesis (Arntz and Wiegand
1991; Brossmer and Arntz 2000; Ulmer et al. 2002;
Vollenweider et al. 2003).
To date, six genera of bacteria that are able to ferment
glycerol into 3-HPA have been identified: Bacillus
(Voisenet 1914a); Klebsiella (Aerobacter) (Abeles et al.
1960; Reymolds et al. 1939; Slininger et al. 1983);
Citrobacter (Mickelson and Werkman 1940); Enterobac-
ter (Barbirato et al. 1996); Clostridium (Humphreys
1924); and Lactobacillus (Mills et al. 1954; Serjak et al.
1954). The enzyme responsible for the formation of 3-
HPA from glycerol, glycerol dehydratase, is known to be
cobamide-dependent (Abeles et al. 1960; Smiley and
Sobolov 1962; Sobolov and Smiley 1960; Toraya 2000).
3-HPA is normally an intracellular intermediate that does
not accumulate but is reduced by an NAD+-dependent
Fig. 1 Formation of hydroxypropionaldehyde (HPA), 1,3-propa-
nediol (1,3-PDO), and acrolein. → Enzymatic reaction; ⇄ equilib-
rium reactions; enzyme 1 glycerol dehydratase; enzyme 2 1,3
propanediol oxidoreductase
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oxidoreductase to 1,3-PDO, the end-product of glycerol
fermentation (Biebl et al. 1999; Daniel et al. 1999; Thiman
1955; Voisenet 1914b; Zeng and Biebl 2002).
The regulation of this pathway is dependent on the
availability of fermentable carbohydrates, in particular
glucose. In fact, the presence of glycerol and its transfor-
mation into 1,3-PDO enables the cells to recover the
NAD+ used during glycolysis. Under conditions of
unlimited glucose, 1,3-PDO will be formed. With
enterobacteria, the presence of glucose will therefore
reduce the yield of 3-HPA production. With lactobacilli, a
molar ratio of glucose to glycerol no greater than 0.33 will
favour the accumulation of 3-HPA. In non-growing
medium (H2O), addition of glucose reduces accumulation
of 3-HPA. Therefore, biotechnological production of 3-
HPA should be performed without glucose, to favour
accumulation of 3-HPA (El-Ziney et al. 1998; Lüthi-Peng
et al. 2002a; Mills et al. 1954; Sauvageot et al. 2000;
Sobolov and Smiley 1960). At high concentrations 3-HPA
is secreted into the medium and can easily be concentrated
by lyophylisation (Slininger et al. 1983; Talarico and
Dobrogosz 1989; Vollenweider et al. 2003). However, the
toxicity of 3-HPA towards bacteria limits the accumulation
of this compound in the fermentation broth medium
(Table 1, studies 1–5).
Two methods have been attempted to overcome this
toxicity and increase the yield for biotechnological
production. In the first method, 3-HPA is entrapped by
semicarbazide (Ulmer et al. 2002), such that 3-HPA
becomes unavailable. This reduces its toxic affect and
prevents its further reduction to 1,3-PDO, increasing the
yield of 3-HPA production. This method resulted in a very
high total production of 621 mM 3-HPA (Table 1, studies
6–8). Although this method is very promising, the
recovery of 3-HPA has never been reported. The second
method uses Lactobacillus reuteri, a species shown to
sustain large amounts of 3-HPA (Table 1, studies 9–10)
produced from glycerol. However, although L. reuteri is
very resistant to high concentrations of 3-HPA, its viability
does decrease when 3-HPA is produced in large quantities.
To further optimise biotechnological production, bacte-
rial strains that are both more efficient and capable of
tolerating large amounts of 3-HPA need to be developed.
To increase efficiency, undesirable by-product formation
should be prevented. Genetic engineering of bacterial
strains might be necessary, as was carried out in some
studies to increase the yield of 1,3-PDO production (Zeng
and Biebl 2002; Cameron et al. 1998). Two enzymatic
targets appear to be of interest to increase the accumula-
tion of 3-HPA. First, the elimination of 1,3-PDO oxido-
reductase activity, which prevents the formation of 1,3-
PDO (Fig. 1); and second, the elimination of glycerol
dehydrogenase (GDH), which forms dihydroxyacetone in
a side reaction (Zeng and Biebl 2002). The development
of bacterial strains capable of transforming glycerol into 3-
HPA via a non-cobamide-dependent glycerol dehydratase
activity also deserves further development (Zeng and
Biebl 2002).
To decrease the inhibitory effect of accumulating 3-
HPA, the use of semicarbazide to entrap 3-HPA (Vancau-
wenberge et al. 1990) warrants further development, in
particular, development of a method to recover the 3-HPA.
The use of semicarbazide for entrapment would have
several advantages. For example, when 3-HPA is in its
semicarbazone form, its inhibitory effect on cells is
reduced, and there is no need to eliminate 1,3-PDO
oxidoreductase activity because the substrate is not
available. The recovery of 3-HPA from semicarbazide
could also be developed as a purification step. Physical
methods for 3-HPA purification such as distillation have
proved difficult because of the high distillation point of
HPA in a concentrated form and the formation of resins
(Hall and Stern 1950; Stepanow and Schtschukin 1927).
Table 1 Biotechnological pro-
duction of 3-hydroxypropional-
dehyde (3-HPA) and 1,3-propa-














1 Lactobacillus sp. 2.34 +a 2 NRRL B-1720 Sobolov and Smiley 1960
2 Lactobacillus sp. 326 95 ndb NRRL B-1720 Slininger et al. 1983
3 Enterobacter agglomerans 725 30 CNCM1210 Barbirato et al. 1996
830 237
4 Citrobacter freudii 760 17 400 ATCC 8090
740
5 Klebsiella pneumonia 760 24 ATCC 25955
780 429
6 K. pneumonia 333 177c nd ATCC 8724 Slininger et al. 1983
7 K. pneumonia 326 220c nd ATCC 8724 Slininger and Bothast 1985
8 K. pneumonia 760 621c nd ATCC 8724 Vancauwenberge et al. 1990
9 Lactobacillus reuteri 250 140 50 1063 Talarico et al. 1988
10 L. reuteri 200 170d nd ATCC 53608 Lüthi-Peng et al. 2002b;




Probiotics are live microbial feed supplements, which
beneficially affect the host by improving its intestinal
microbial balance (Tannock 1999). They can inhibit
pathogenic bacteria due to the production of antimicrobial
compounds. Axelsson et al. (1988) were the first to report
an antimicrobial compound produced by L. reuteri, a
bacterial strain known to inhabit the gastrointestinal tract
of all vertebrates and mammals (Casas and Dobrogosz
2000). The antimicrobial agent was described as an anti-
fungal, anti-parasite, anti-viral and anti-cancer agent as
well as an antibacterial agent (Dobrogosz and Lindgren
1988; Dobrogosz et al. 1989) and named reuterin, after the
producing strain. Reuterin has a broad spectrum of
antimicrobial activity against prokaryotes (both Gram+
and Gram−) and eukaryotes (Saccharomyces cerevisiae
and Trypanosoma cruzi). Further characterisation of
reuterin revealed the presence of 3-HPA, HPA-hydrate,
and HPA-dimer (Axelsson et al. 1988; Talarico and
Dobrogosz 1989). Today the name reuterin is used as a
synonym for the HPA system, mostly in the field of food
preservation and health care.
A detailed review validating the use of L. reuteri as a
probiotic has been published (Casas and Dobrogosz 2000),
and the company, BioGaia, established a web-site on this
topic (http://www.reuteri.com). Some of this information
is summarised below. L. reuteri has been shown to survive
the effects of gastric acid and bile salts in the stomach and
upper intestine; bind to the gut mucus and epithelial cells;
and to colonise the intestine. L. reuteri is expected to
reduce the risk of diarrhoea among children and can
significantly lower the incidence of watery diarrhoea
among children suffering from rotavirus diarrhoea. It may
also reduce Helicobacter pylori infections (Mukai et al.
2002; Shornikova et al. 1997). Finally, trials have shown
that L. reuteri has a positive influence on the development
of ileal tissue, thereby enhancing absorption of nutrients.
Safety studies have been conducted on healthy newborns,
small children, adults and immunodeficient adults (HIV
positive) (Wolf et al. 1995, 1998). In all studies, L. reuteri
has been shown to be free from side effects, even when
administered in doses largely exceeding the levels
normally contained in products containing L. reuteri
(Casas and Dobrogosz 1997); a few individuals experi-
enced a temporary increase in flatulence.
In animal studies, a cholesterol-lowering effect and
significant strengthening of the immune defence have also
been documented. With animals raised for meat produc-
tion, administration of L. reuteri to newly hatched/
newborn animals led to better feed utilisation and growth
than in the control groups. Sickness and mortality rates
were also lower. Additionally L. reuteri has been shown to
modulate immune responses in a series of animal models;
such immuno-modulation may be one of the basic
mechanisms by which L. reuteri exerts its probiotic effects
in man (Valeur et al. 2002). In conclusion, supplementing
food products such as tablets and milk products with L.
reuteri, the only species shown to accumulate high
amounts of 3-HPA in vitro, potentially offers a wide
range of benefits to the consumer (Klantschitsch et al.
1996; Reid 1999). However, it is not yet known whether
reuterin production occurs in vivo, and if this production is
responsible for the health effects of L. reuteri. BioGaia is
currently the main producer and sells L. reuteri-containing
products through licensed partners worldwide (Table 2).
HPA system as the antibiotic reuterin
Biotechnologically produced HPA could be used to protect
food against microbial spoilage. The anti-bacterial activity
of reuterin has been shown to inhibit the growth of Listeria
monocytogenes and Escherichia coli O157:H7 in meat
products, milk and cottage cheese (Table 3).
For health care or pharmaceutical applications, reuterin
has also been shown to be a useful agent in the sterilisation
and fixation of biological tissues. Indeed, the use of
reuterin for fixation is more efficient than using glutaral-
dehyde, and is less cytotoxic (Table 3). Treatment of
Trypanosoma brucei brucei-infected mice with reuterin for
7 days led to a 61% reduction in bacterial numbers and to
an increased survival of the mice (Table 3). HPA can
therefore be described as a potent agent that shows
Table 2 Use of L. reuteri as a
probiotic in different countries
Country Company Products
Sweden BioGaia AB Tablets, capsules, powder and infant
formula; milk, yogurt, juice, fresh cheese
and ice-cream
Finland Ingman Foods Oy Ab Yoghurts, fermented milks, cottage cheese,
ice-cream, and fruit drinks
Great Britain Farm Produce Marketing Ltd. Yogurt drink
Japan Chichiyasu milk products
company Ltd.
Milk products
Spain and Portugal Kraft Jacobs Suchard Iberia Fresh cheese
South Korea Lotte Ham & Milk Co., Ltd. Dairy products
Sweden Milko Dairy products
USA Stonyfield Farm Yoghurt products
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potential as a food preservative while also offering
pharmaceutical benefits.
For the use of HPA, or reuterin, in food preparations L.
reuteri, a probiotic strain, could be used to produce HPA in
glycerol-containing water (Vollenweider et al. 2003). HPA
concentrations reached by this method (170 mM) are
sufficient to achieve an inhibitory effect, and the super-
natant can be used directly without further purification
after production when food-grade culture medium is used
(El-Ziney and Debevere 1998; El Ziney et al. 1999). For
pharmaceutical application, a purified preparation of HPA
would be needed (Chen et al. 2002). The purified extract
should contain only solvents, which could be totally
eliminated after purification (Vollenweider et al. 2003).
Mode of action and biological safety
Given the complexity of the HPA/reuterin system (Fig. 1)
the question of which molecule (3-HPA, HPA-dimer or
HPA-hydrate) is the active substance conferring anti-
microbial activity arises. Dobrogosz (Dobrogosz and
Lindgren 1988) made a first attempt to identify the active
compound and proposed a carbohydrate-like structure for
reuterin. A three-dimensional molecular model of the
hemiacetal revealed a molecule that closely resembled a
pentose such as D-ribose. It was then postulated that
reuterin was able to compete with ribonucleotides for
binding to the ribose recognition site of ribonucleotide
reductase, the first enzyme involved in DNA synthesis.
Thus, reuterin might inhibit the conversion of ribonucleo-
tides into deoxyribonucleotides and hence exert its anti-
microbial effect (Dobrogosz and Lindgren 1988; Talarico
and Dobrogosz 1989). However, the observed inhibition
of ribonucleotide reductase and thioredoxin by HPA might
also be explained by another hypothesis involving the
functional groups of the aldol 3-HPA. The hydroxyl and
the aldehyde group might be responsible for the relative
reactivity of the HPA monomer, which might cause it to
react with unstable sulfhydryl groups of ribonucleotide
reductase and thioredoxin (Schauenstein et al. 1977).
Using quantitative 13NMR Vollenweider et al. (2003)
recently found that the composition of the HPA system
was concentration dependent (Fig. 2).
At high concentrations (4.9 M), the HPA system was
predominantly composed of HPA-dimer along with
unspecified HPA derivatives. At intermediate concentra-
tions (1.2 M) equal amounts of HPA-dimer and HPA-
Table 3 Use of reuterin as an
antimicrobial and fixation agent.
MIC Minimal inhibitory con-
centration, AU Reuterin activity
unit defined as reciprocal of the
highest dilution that did not
permit growth of the indicator
strain, U 1 U =5 μg reuterin/ml
aCalculation based on HPA
dimer
bCalculation based on HPA
monomer
Application Concentration used Reference
Bacteria, yeast, fungi, protozoa 2–42 MIC Dobrogosz et al. 1989
Bacteria
Salmonella typhimurium 0.35–0.42a (0.7–0.84)b mM
Bacteria 50–100 U/g ground beef Daeschel 1989
Coliforms
Protozoa <35a (70)b μM Yunmbam and Roberts 1992
Trypanosoma brucei brucei
Vertebrates, mice LD50 1,500 U (7.5 mg) Yunmbam and Roberts 1993
Protozoa in vertebrate
Trypanosoma brucei brucei in mice 300 U/ml (1.5 mg)
Bacteria E. agglomerans, C. freudii,
K. pneumonia
30 mM Barbirato et al. 1996
Bacteria 50–250 AU/g (cottage cheese) El-Ziney and Debevere 1998;
El Ziney et al. 1999Listeria monocytogenes 150 AU/ml (UHT skim milk)
Escherichia coli O157:H7 100–500 AU/g (meat surface)
Bacteria 0–4 AU/ml Rasch 2002
E. coli
Bacteria 20–35 ppm Chen et al. 2002;




Fig. 2 Concentration-dependent distribution of the three forms of
the HPA system in aqueous solution at 20°C measured by
quantitative 13C NMR (Vollenweider et al. 2003)
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hydrate were observed. At further dilution the fraction of
dimer decreased rapidly and was replaced mainly by HPA-
hydrate. Equal amounts of HPA-dimer and 3-HPA were
present at a concentration of 0.4 M. At the very low
concentration of 0.03 M, the system was composed mainly
of HPA-hydrate (69%), followed by 3-HPA (27%) and
HPA-dimer (4%), whereas no derivatives could be
detected. Further extrapolation of the curve suggests that
the HPA system is likely to have a similar composition at
concentrations below 0.03 M.
In some studies where HPA was used as an anti-
microbial agent, reported molar concentrations were
calculated using the molecular mass of the dimer form
(Table 3). However, Fig. 2 clearly shows that HPA occurs
mainly in its monomeric form at the concentrations used.
This implies that the concentrations used in these studies
were actually twice as high as those reported (Table 3).
The composition of HPA has also been reported to be
pH-dependent, forming mainly aldol dimer and polymers,
or hemicacetal dimer, acetal trimer and polymers (Chen et
al. 2002; Sung et al. 2003). All these molecules have
aldehyde groups and have been reported to react with the
amino groups in biological tissues (Sung et al. 2003). In
contrast, in organic solutions the dimeric and polymeric
forms seem to be predominant (Talarico and Dobrogosz
1989; Vollenweider et al. 2003). Hence, the composition
of the HPA system is highly dynamic, which greatly
affects its biological activity.
Detailed studies are needed to elucidate the mode of
action of reuterin and the active component in vivo. A first
step would be to accurately determine the concentration of
HPA in aqueous solutions. Until now, no standardised unit
is used to express the concentration of HPA (Table 3). The
method for acrolein determination, using the acid-
catalysed formation of a coloured complex between
acrolein/HPA and tryptophan (Circle et al. 1945) has
been adopted by several authors to accurately determine
the molar concentration of HPA (Barbirato et al. 1996;
Lüthi-Peng et al. 2002b; Sauvageot et al. 2000; Slininger
et al. 1983; Smiley and Sobolov 1962; Vollenweider et al.
2003). Indeed, the use of molar concentrations would
enable researchers to compare the anti-microbial activity
of HPA in different biological systems as well as compare
its activity to that of other molecules.
Another important consideration for biotechnological
applications of HPA in foods is the accumulation of
acrolein due to thermal dehydration (Nef 1904; Schütz and
Radler 1984; Voisenet 1914a). Acrolein reacts with
phenolic compounds, especially tannins present in alco-
holic beverages, resulting in a bitter taste (Mills et al.
1954; Rentschler and Tanner 1951; Serjak et al. 1954).
This spoilage of alcoholic beverages has been known since
the eighteenth century, yet it remains a problem today and
is an important topic of research (Claisse and Lonvaud-
Funel 2001; Noble 1999; Sauvageot et al. 2000; Sponholz
1993). Acrolein is an α,β-unsaturated aldehyde, which
reacts with other molecules especially those containing
sulfhydryl groups (e.g. proteins containing cysteine),
causing the depletion of glutathione—one of the most
important antioxidants—and/or general enzyme inhibition.
Most human contact with acrolein occurs during exposure
from incomplete combustion, such as that generated by
cigarettes, automobiles, industrial processes, heating of
animal and vegetable cooking oils, and burning (Ghilar-
ducci and Tjeerdema 1995). Mucosal irritation has been
observed at 1–2 mg/m3. Death in humans has occurred at
351 mg/m3. Fortunately, the odour perception of acrolein
is 0.07 mg/m3 (Ghilarducci and Tjeerdema 1995).
HPA is stable at 4°C, hence its use in foods such as milk
products, which are stored at or below 4°C and are not
heated, may be considered safe (El-Ziney and Debevere
1998; Vollenweider et al. 2003). However, at higher
temperatures HPA becomes unstable and may react with
other components present (Lüthi-Peng et al. 2002b; Sung
et al. 2003). Therefore in heated food preparations
containing HPA, the formation of acrolein is a risk
requiring careful consideration. In-depth studies need to be
carried out to demonstrate the safety of HPA in different
foods (Ghilarducci and Tjeerdema 1995; Kehrer and
Biswal 2000; Lüthi-Peng et al. 2002b; Sung et al. 2003).
HPA as a biotechnological precursor in the production
of bulk chemicals
The value of HPA as a precursor in the production of
useful industrial chemicals, for example plastics, was
mentioned as early as 1950 (Hall and Stern 1950), and
later for the production of acrylic acid. Slininger and
colleagues (Slininger and Bothast 1985; Slininger et al.
1983) described the first attempt to produce HPA from
renewable resources using modern biotechnology as an
alternative for the production of major bulk chemicals.
Acrolein
Acrolein is produced chemically from propylene by direct
catalytic oxidation, but the highest reported yield in the
oxidation process is only 8% (Hess et al. 1978). The main
uses of acrolein are as an intermediate in the synthesis of
numerous chemicals, in particular acrylic acid and its
lower alkyl esters, and DL-methionine, an essential amino
acid. The most significant direct application of acrolein is
as a herbicide to control the growth of aquatic plants. It
kills plant cells by its reactivity with biological molecules
and the destruction of cell membrane integrity (Ashton and
Crafts 1981), as well as by its affinity for sulfhydryl
groups, which causes the elimination of vital enzymatic
pathways (WSSA 1983).
Acrolein is very polar and highly soluble in water. An
aqueous acrolein solution has been reported to consist
predominantly of HPA-hydrate, with about 92% under
laboratory conditions, or even higher in river water
(Bowmer and Higgins 1976; Bowmer and Sainty 1977;
Ghilarducci and Tjeerdema 1995; O’Loughlin and Bow-
mer 1975). Other biological degradation products include
3-hydroxypropionic acid, allyl alcohol, acrylic acid,
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propionic acid, HCO3
−, glyceric acid, 1,3-PDO, oxalic
acid, propanol and butyric acid (Mao et al. 1994). All of
these products are polar and highly soluble in water.
Bioassays have shown that aqueous acrolein solutions
become biocidally inactive after 120–180 h, probably as a
result of volatilisation of the compounds from water
(Kissel et al. 1978; WHO 1992).
The formation of HPA from acrolein-containing solu-
tions is reversible, as was mentioned previously for
alcoholic beverages. Acrolein is accumulated by thermal
dehydration during glycerol fermentation after the nearly
complete disappearance of fermentable carbohydrates (El-
Ziney et al. 1998; Lüthi-Peng et al. 2002a; Mills et al.
1954; Sauvageot et al. 2000; Sobolov and Smiley 1960).
Probiotic strains such as L. reuteri produce 3-HPA in the
bacterial supernatant in concentrations up to 170 mM
(Table 1). For use as a herbicide, concentrations of 6–
10 mg/l (0.11–0.17 mM) acrolein are required. Thus,
biotechnological fermentation of glycerol into 3-HPA
followed by heating of the bacterial supernatant, thus
producing acrolein, could provide an inexpensive alter-
native, requiring no further purification, to chemically-
produced, high quality acrolein.
Acrylic acid
Acrylic acid is a petrochemical that is modified and
polymerised into a broad range of versatile chemicals and
resins for the production of viscosity modifiers and
flocculants. Roughly three-quarters of its world production
is converted directly into acrylate esters, the remainder
being purified into glacial acrylic acid (Burridge 2002).
The demand for acrylic acid has been rapidly increasing
from a mere 400,000 t in 1980, to 3.4 million t in 2002.
This increase is mainly due to the increasing use of super
absorber polymers in the hygiene industry. World capacity
is predicted to rise to 4 million t/year by 2009 (Burridge
2002).
Acrylic acid is made via acrolein by gas-phase catalytic
oxidation of propylene; it is a hydrocarbon gas, and a by-
product of oil refineries. The process is not very selective
(Burridge 2002; Danner and Braun 1999). Several
attempts have been made using different bacterial species
to produce acrylic acid biotechnologically (Danner and
Braun 1999; Danner et al. 1998). So far, acrylic acid has
been produced by bacteria from acrylonitrile (Nagasawa et
al. 1990; Narayanasamy et al. 1990) and from acrylamide
(Nawaz et al. 1993, 1994), the highest yield being
obtained from acrylonitrile (390 g/l). Both the afore-
mentioned substrates are secondary products that must be
produced from other raw materials. Therefore, as sug-
gested by several researchers, oxidation of HPA to acrylic
acid may present a new alternative with great potential for
the production of acrylic acid (Lüthi-Peng et al. 2002b;
Slininger et al. 1983; Ulmer et al. 2002). However, no
method has been described to date.
1,3-PDO and hydroxypropionic acid
1,3-PDO is used as a bulk chemical for polymer
production, especially in the manufacture of the aromatic
polyester PTT (polytrimethylene terephthalate) sold by
Shell and DuPont under the trademarks CORTERRA and
Sorona, respectively. This polymer exhibits properties
desirable in carpets and textiles. Compared with other
synthetic fibers like nylon, PTT fibers feel softer, dye
more easily, retain vibrant colours longer, stretch and
recover better, clean easily and dry quickly (http://www.
eurekalert.org/pub_releasees/2003–02/d-cfc012903.php).
The demand for PTT is therefore expected to exceed
1 million metric tonnes by the year 2010 (http://www.
search.shellchemicals.com). Currently 1,3-PDO is made
using two different petroleum-based processes. Both
methods use 3-HPA as an intermediate, which is
hydrogenated with metal catalysts under high pressure
(see section on petrochemically derived 3-HPA).
1,3-PDO is one of the oldest known fermentation
products. It was first identified in 1881 by August Freund
in a glycerol-fermenting mixed culture containing Clos-
tridium pasteurianum (Freund 1881). Although the great
potential of 1,3-PDO has long known been recognised, the
expensive chemical synthesis has prevented its commer-
cial production (Morris and Snider 1950). Over the past
few years, extensive work has been done to increase the
productivity and yield of biotechnological processes able
to generate 1,3-PDO (Cameron et al.1998). The biological
system developed by DuPont and Genencor, based on
transformed E. coli, produces 129 g/l 1,3-PDO after 74 h,
using sugar from corn and other crops (Emptage et al.
2003). However, the yield of 34% (g 1,3-PDO/g glucose)
is quite low. 1,3-PDO can also be obtained by the
fermentation of glycerol, with a theoretical yield of 67%,
since additional products need to be formed to generate
sufficient NADH+ for the reduction of 3-HPA to 1,3-PDO
by enzymes (Wittlich 2001). Depending on the price of
glycerol, the latter process could still be favoured over the
former.
The biotechnological production of 3-HPA followed by
its chemical reduction to 1,3-PDO offers great potential
(Ulmer et al. 2002; Valerius et al. 1996). As stated above,
L. reuteri can accumulate up to 12.5 g/l (170 mM) 3-HPA
with a yield of 0.68 g HPA/g glycerol, under unoptimised
conditions (Lüthi-Peng et al. 2002b; Vollenweider et al.
2003). The theoretical yield would be 0.8 g 3-HPA per
gram glycerol (Slininger et al. 1983). In addition, the
purity of 3-HPA produced in water containing glycerol
reaches 87%. The 3-HPA thus generated could be easily
hydrogenated using existing chemical methods, with
yields of up to 99% (Brossmer and Arntz 2000; Etzkorn
et al. 2000). Alternatively, in the presence of semicarba-
zide, Klebsiella was shown to accumulate up to 46 g/l
(621 mM) 3-HPA from glycerol (Vancauwenberge et al.
1990). Although perhaps offering great potential for the
future, so far no method has been reported for the recovery
of HPA from its semicarbazide form.
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3-Hydroxypropionic acid (3-HP), a molecule that has
recently attracted considerable attention, can be chemi-
cally produced from sodium hydroxide and ethylene
cyanohydrine (Read 2002). 3-HP will be used in the
manufacture of coatings, adhesives, water-treatment che-
micals and personal-care products. Cargill (http://www.
cargill.com) and the United States Department of Energy
will invest over US $6 million to produce 3-HP
biotechnologically (CEP 2003; Gokarn et al. 2002).
Additionally, 3-HP is used as a substrate by specialised
bacteria and transgenic plants to produce polyhydroxyalk-
anoates, a raw material for biodegradable plastics
(Mittendorf et al. 1998). 3-HP has been described by
several authors to be produced from 3-HPA during
glycerol fermentation leading to equal molar concentra-
tions of 1,3-PDO and 3-HP (Slininger et al. 1983; Sobolov
and Smiley 1960; Talarico et al. 1988).
Polymers
The last two decades have shown a steady increase in
polymer research. In 1980, less than 50 new patents
concerned polymers, while in 2001 over 1,100 patents on
polymers were published. Of these patents, only 25–30%
dealt with petrochemical polymers; the vast majority
concerned biopolymers, both starch polymers and natural
polyesters. Today about 200 million tonnes are used
compared with about 60 million tonnes in 1980. This
demand is predicted to increase to about 260 million
tonnes by 2010 (Lörcks 2000). As already discussed,
polymers can be generated from HPA via 1,3-PDO;
however, HPA can also transform itself into polymeric
derivatives and resins (Fig. 3) (Hall and Stern 1950;
Nielsen et al. 1981; Sung et al. 2003).
To date, no study has addressed the issues of controlled
production or the various uses of polymeric derivatives. In
theory, careful manipulation of experimental conditions
such as concentration, solvent, pH, and temperature may
provide an important tool to control the synthesis of
specific polymers.
Economical considerations
The petrochemical industry is still one of the world’s most
important industries, with a steadily rising demand for its
products. Current estimates predict a 5-fold increase in
demand for chemicals and consumables by 2020, and
another 5-fold increase between then and the year 2050
(Inverizon International 1998). The availability of petro-
chemicals is largely determined by political forces, and the
source of raw material is limited. Consequently, the price
of petroleum has steadily increased since 1970 from about
US $3/barrel to US $30/barrel today.
Renewable resources from plants, as well as agricultural
wastes transformed by bacteria, can provide many of the
same chemical building blocks as the petrochemical
industry, as well as some new ones. The costs of plant-
derived materials are largely dependent on weather
conditions. Of great importance is the ecological impact.
Plant-derived materials may lead to increased monoculture
in agriculture and increased plant production may only be
possible with genetically modified plants. However, it is
expected that the use of fossil fuels will stabilise at
approximately current levels and that the increasing
demand for chemicals will be met through bio-transfor-
mation and biotechnological engineering using renewable
resources (de Boer and Schmidt-Dannert 2003; Inverizon
International 1998). Already, the increasing number of
Fig. 3 Different forms of 3-HPA in acidic and/or basic aqueous solutions; adapted from Sung et al. (2003)
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patents in this area is indicative of the increasing trend in
this industry.
As presented above, 3-HPA can be produced by bacteria
by the fermentation of glycerol. Theoretically, the devel-
opment of strains using fermentable carbohydrates such as
glucose as substrate, which cost 3–5 times less than
glycerol, is desirable. The example of 1,3-PDO shows the
feasibility of this approach. However, since glucose can
also be transformed into a wide range of products other
than those of interest, the resulting yield and purity of the
final product is low. The theoretical yield of the one-step
enzymatic transformation process from glycerol to 3-HPA
is 1 mol HPA/mol glycerol. Production can be accom-
plished in water, into which 3-HPA is secreted. This
results in increased purity and yield. Bacterial strains using
a non-cobamide-dependent glycerol dehydratase may be a
valuable tool for decreasing the cost of 3-HPA production
(Zeng and Biebl 2002).
Glycerol is formed as a side-product during the
production of soap, fatty acids, and biodiesel. Experts
predict a tremendous increase in the annual production of
biodiesel from 2.7 million tonnes today to about 7–
9 million tonnes by 2010 (Widmer and Müller 2003).
Roughly 10% of this production will be in the form of
glycerol. The expansion of the biodiesel market will
therefore lead to an increased glycerol production,
concomitant with a decrease in price (Fig. 4).
An additional source for glycerol may be the increased
production during ethanol fermentation without changing
the ethanol yield. As cited by Zeng and Biebl (2002) High
Plains Corporation (York, Neb.) plans to recover glycerol
(99.7%) from ethanol fermentation broth by a novel
filtration process at costs below US $300–400/t, which is
well below the cost of glycerol on the market (Fig. 4).
Production of 600,000 t/year would be possible, which
would have a significant economic impact on the glycerol
market and price.
The use of 3-HPA as a preservation agent in food or as a
disinfectant in the pharmaceutical field is not much
affected by these economic considerations. However, as
a potential source of bulk chemicals, the price of
biotechnologically produced 3-HPA and thus of glycerol
will be of major importance to the viability of this
industry, as it has to compete with the chemical industry
(Table 4).
HPA biotechnology—conclusions and future trends
The HPA system is composed of different derivatives that
create the basis for its outstanding chemical properties.
Biotechnologically produced HPA may find applications
in health care, in the food industry, and in the chemical
industry (Fig. 5).
Due to its broad antimicrobial activity, the 3-HPA-
producing bacterium L. reuteri is used as a probiotic strain
in human and animal diets to positively influence the
microbial balance in the intestine. L. reuteri was shown to
produce two other molecules with antimicrobial activity:
reutericyclin (Gänzle and Vogel 2003; Holtzel et al. 2000)
and reutericin (Kabuki et al. 1997; Toba et al. 1991).
However, the production of both of these molecules in
vivo has not yet been tested. The interaction of HPA with
reutericyclin and reutericin warrants further research
because these molecules may play a synergistic role in
the protection of L. reuteri, and therefore of the host,
against pathogenic bacteria.
The “antibiotic” properties of reuterin are known to
inhibit the growth of several human pathogens, including
protozoa, viruses, and bacteria (Dobrogosz and Lindgren
1988), which make it attractive for use as a food
Table 4 Current price of chemicals. PTT Polytrimethylene
terephthalate




PTT 1.000d to <1.500e
aMarket research, bCelanese AG, cNo information available, dZeng
and Biebl (2002), eSchoenberger (2003)
Fig. 4 Development of glycerol price and production since 1995.
The price is for refined glycerol. (Procter & Gamble Chemicals,
2003 personal communication; HB International, 2003 personal
communication)
Fig. 5 Potential applications of biotechnologically produced HPA
in industry
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preservation and conservation agent (Fig. 5). HPA is
produced by a probiotic strain and is excreted into the
medium. In the future, productivity may be improved by
optimising the fermentation strategy, culture conditions,
and purification strategy, as well as by genetic engineer-
ing. An HPA-enriched medium could be used directly for
applications in foods (El-Ziney and Debevere 1998; El
Ziney et al. 1999); alternatively HPA may also be purified
from bacterial supernatants by existing methods if
necessary (Vollenweider et al. 2003).
In combination with other antimicrobial molecules,
such as bacteriocins, HPA may also reveal synergistic
effects that could help to overcome the increasing
resistance of bacteria against antibiotics. HPA was also
reported to be a useful chemical in the fixation of
biological tissues, with equal fixation possibilities but
less cytotoxic effects than glutaraldehyde, a chemical
frequently used for this purpose (Sung et al. 2002, 2003).
The proven low cytotoxic effect of HPA makes it an ideal
molecule for future use in biological systems. However,
HPA has been shown to react with other molecules in
complex media, particularly when heated (Lüthi-Peng et
al. 2002b; Sung et al. 2002, 2003). Under certain
conditions, acrolein, a very toxic aldehyde, may be
formed, leading to food spoilage (Lüthi-Peng et al.
2002b; Mills et al. 1954; Reymolds et al. 1939; Sauvageot
et al. 2000; Serjak et al. 1954). Time-temperature
combinations, physicochemical characteristics and the
chemical composition of foods may affect these reactions,
but very little information is available on this important
issue. Therefore heat-treated foods containing HPA should
be carefully surveyed, and detailed studies are needed to
elucidate the mode of action of HPA in biological systems.
Finally, HPA can be used as a precursor in enzymatic and
chemical reactions for the preparation of bulk chemicals
such as acrolein, acrylic acid, 1,3-PDO and in the
formation of biopolymers. However, large-scale synthesis
of these HPA-derived compounds will also require
optimisation of biotechnological production and purifica-
tion in order to produce HPA with high yields and low
costs.
We may thus anticipate that, after the optimisation of its
biotechnological production, HPA will probably achieve a
biotechnological importance similar to that of 1,3-PDO.
Acknowledgements We thank Prof. Dr. Puhan for critical advice.
We thank Prof. Hsing-Wen Sung, Mr. Donald B. Appleby (Procter
& Gamble Chemicals), and Mr. Valéry Desroches (HB International
S.A.), for kindly providing data for the figures presented in this
work. We thank Mr. Heinz Trogemann (Stockhausen GmbH & Co.
KG) and Mrs. Albrecht (Celanese AG) for providing information on
the price of acrylic acid, and Joseph W. Carroll (DuPont Co.) for
helpful discussions. The authors would like to offer special thanks to
Annemieke Ijpenberg and Janice Sych for critical review.
References
Abeles RH, Brownstein AM, Randles CH (1960) β-Hydroxypro-
pionaldehyde, an intermediate in the formation of 1,3-
propanediol by Aerobacter aerogenes. Biochim Biophys Acta
41:530–531
Arntz D, Wiegand N (1991) Method of preparing 1,3-propanediol.
US Patent 5 015 789
Ashton FM, Crafts AS (1981) Mode of action of herbicides. Wiley,
New York
Axelsson L, Chung TC, Dobrogosz WJ, Lindgren SE (1988)
Production of a broad-spectrum antimicrobial substance
produced by Lactobacillus reuteri. Microb Ecol Health Dis
2:131–136
Barbirato F, Grivet JP, Soucaille P, Bories A (1996) 3-Hydro-
xypropionaldehyde, an inhibitory metabolite of glycerol fer-
mentation to 1,3-propanediol by enterobacterial species. Appl
Environ Microbiol 62:1448–1451
Berzelius J (1839) Lehrbuch der Chemie. Dresden und Leipzig
Biebl H, Menzel K, Zeng AP, Deckwer WD (1999) Microbial
production of 1,3-propanediol. Appl Microbiol Biotechnol
52:289–297
Boer AL de, Schmidt-Dannert C (2003) Recent efforts in
engineering microbial cells to produce new chemical com-
pounds. Curr Opin Chem Biol 7:273–278
Bowmer KH, Higgins ML (1976) Some aspects of the persistence
and fate of acrolein herbicide in water. Arch Environ Contam
Toxicol 5:87–96
Bowmer KH, Sainty E (1977) Management of aquatic plants with
acrolein. J Aquat Plant Manage 15:40–46
Brossmer C, Arntz D (2000) Process for the production of 1,3-
propanediol. US Patent 6 140 543
Burridge A (2002) Product profile: acrylic acid. European Chemical
News 16–22 September, Reed Business Information
Cameron DC, Altaras NE, Hoffman ML, Shaw AJ (1998) Metabolic
engineering of propanediol pathways. Biotechnol Prog 14:116–
125
Casas IA, Dobrogosz WJ (1997) Lactobacillus reuteri: overview of
a new probiotic for humans and animals. Microbiol Ther
26:221–231
Casas IA, Dobrogosz WJ (2000) Validation of the probiotic concept:
Lactobacillus reuteri confers broad-spectrum protection against
disease in humans and animals. Microb Ecol Health Dis 12:285
CEP (2003) Engineering 1,3-carbon molecules. AIChE, New York,
www.cepmagazine.org. Cited 14 February 2003
Chen CN, Sung HW, Liang HF, Chang WH (2002) Feasibility study
using a natural compound (reuterin) produced by Lactobacillus
reuteri in sterilizing and crosslinking biological tissues. J
Biomed Mater Res 61:360–369
Chevreul ME (1823) In: Levrault (ed) Recherches sur les corps gras
d’origine animale. Paris
Circle SJ, Stone L, Boruff CS (1945) Acrolein determination by
means of tryptophan. Ind Eng Chem 17:259–262
Claisse O, Lonvaud-Funel A (2001) Primers and a specific DNA
probe for detecting lactic acid bacteria producing 3-hydro-
xypropionaldehyde from glycerol in spoiled ciders. J Food Prot
64:833–837
Daeschel MA (1989) Antimicrobial substances from lactic acid
bacteria for use as food preservatives. Food Technol 43:164–
167
Daniel R, Bobik TA, Gottschalk G (1999) Biochemistry of
coenzyme B12-dependent glycerol and diol dehydratases and
organization of the encoding genes. FEMS Microbiol Rev
22:553–566
Danner H, Braun R (1999) Biotechnology for the production of
commodity chemicals from biomass. Chem Soc Rev 28:395–
405
Danner H, Ürmös M, Gartner M, Braun R (1998) Biotechnological
production of acrylic acid out of biomass. Appl Biochem
Biotechnol 70–72:887–894
Dobrogosz WJ, Lindgren SE (1988) Antibiotic reuterin. US Patent
PCT/US88/01423
25
Dobrogosz WJ, Casas IA, Pagano GA, Sjöberg B-M, Talarico TL,
Karlsson M (1989) Lactobacillus reuteri and the enteric
microbiota. In: Grubb R, Midtvedt T, Norin E (eds) The
regulatory and protective role of the normal microflora.
MacMillan, London, pp 283–292
El-Ziney MG, Debevere J (1998) The effect of reuterin on Listeria
monocytogenes and Escherichia coli O157:H7 in milk and
cottage cheese. J Food Prot 61:1275–1280
El-Ziney MG, Arneborg N, Uyttendaele M, Debevere J, Jakobsen M
(1998) Characterization of growth and metabolite production of
Lactobacillus reuteri during glucose/glycerol cofermentation in
batch and continuous cultures. Biotechnol Lett 20:913–916
El Ziney MG, van den Tempel T, Debevere J, Jakobsen M (1999)
Application of reuterin produced by Lactobacillus reuteri
12002 for meat decontamination and preservation. J Food Prot
62:257–261
Emptage MH, Sharon L, Laffend LA, Pucci JP, Whited G (2003)
Process for the biological production of 1,3-propanediol with
high titer. US Patent 6 514 733
Etzkorn WG, Brockwell JL, Young MA, Maher JM, Warren BK
(2000) Production of 1,3-propanediol from 3-hydroxypropio-
naldehyde. US Patent 6 166 263
Freund A (1881) Über die Bildung und Darstellung von Trimethy-
lenalkohol aus Glycerin. Monatsh Chem 2:636–641
Gänzle MG, Vogel RF (2003) Studies on the mode of action of
reutericyclin. Appl Environ Microbiol 69:1305–1307
Geoffroy CJ (1742) Method of making soap-lees and hard soap, for
medicinal uses. Phil Trans R Soc London 42:71–77
Ghilarducci DP, Tjeerdema RS (1995) Fate and effects of acrolein.
Rev Environ Contam Toxicol 95–146
Gokarn RR, Selifonova OV, Jessen HJ, Gort SJ, Selmer T, Buckel
W (2002) 3-Hydroxypropionic acid and other organic com-
pounds. Canadian Patent 2429039
Hall RH, Stern ES (1950) Acid-catalysed hydration of acrylalde-
hyde: kinetics of the reaction and isolation of β-hydroxypro-
paldehyde. J Chem Soc 490–498
Hess LG, Kurtz AN, Stanton DB (1978) Acrolein and derivatives.
In: Grayson M, Eckroth D (eds) Kirk-Othmer encyclopedia of
chemical technology. Wiley, New York, pp 277–297
Holtzel A, Gänzle MG, Nicholson GJ, Hammes WP, Jung G (2000)
The first low molecular weight antibiotic from lactic acid
bacteria: reutericyclin, a new tetramic acid. Angew Chem Int
Ed Eng 39:2766–2768
Humphreys FB (1924) Formation of acrolein from glycerol by B.
welchii. J Inf Dis 35:282–290
Inverizon International (1998) Technology Roadmap for Plant/Crop-
Based Renewable Resources 2020. Inverizon International,
Chesterfield, Mo., http://www.oit.doe.gov/agriculture/pdfs/
technology_roadmap.pdf
Kabuki T, Saito T, Kawai Y, Uemura J, Itoh T (1997) Production,
purification and characterization of reutericin 6, a bacteriocin
with lytic activity produced by Lactobacillus reuteri LA6. Int J
Food Microbiol 34:145–156
Kehrer JS, Biswal SS (2000) The molecular effects of acrolein.
Toxicol Sci 57:6–15
Kissel CL, Brady JL, Guerra AM, Pau JK, Rockie BA, Caserio FF Jr
(1978) Analysis of acrolein in aged aqueous media. Compar-
ison of various analytical methods with bioassays. J Agric Food
Chem 26:1338–1343
Klantschitsch T, Spillmann H, Puhan Z (1996) Lactobacillus reuteri:
Ein milchwirtschaftlicher Neuling. DMZ Lebensm-Ind Milch-
wirtsch 17:790–797
Knifton JF, Slaugh LH, Weider PR, James TG, Powell JB, Allen
KD, Williams TS (2003) One step process for preparing a 1,3-
diol. US Patent 6 518 466
Lörcks J (2000) Biologisch abbaubare Werkstoffe. Fachagentur
Nachwachsende Rohstoffe, Gülzow, Germany
Lüthi-Peng Q, Dileme FB, Puhan Z (2002a) Effect of glucose on
glycerol bioconversion by Lactobacillus reuteri. Appl Micro-
biol Biotechnol 59:289–296
Lüthi-Peng Q, Schärer S, Puhan Z (2002b) Production and stability
of 3-hydroxypropionaldehyde in Lactobacillus reuteri. Appl
Microbiol Biotechnol 60:73–80
Mao J, Doane R, Kovacs MF Jr (1994) Separation of acrolein and its
possible metabolites using different modes of high performance
liquid chromatography. J Liquid Chrom 17:1811–1819
Matagrin A (1925) Chevreul et la bougie stéarique. Ind Chim
12:400–402
Mickelson MN, Werkman CH (1940) The dissimilation of glycerol
by coli-aerogenes intermediates. J Bacteriol 39:709–715
Mills E, Baugh WD, Conner HA (1954) Studies on the formation of
acrolein in distillery mashes. Appl Microbiol 2:9–13
Mittendorf V, Robertson EJ, Leech RM, Kruger N, Steinbüchel A,
Poirier Y (1998) Synthesis of medium-chain-length polyhy-
droxyalkanoates in Arabidopsis thaliana using intermediates of
peroxisomal fatty acid beta-oxidation. Proc Natl Acad Sci USA
95:13397–13402
Morris RC, Snider AV (1950) Polymers of trimethylene glycol. US
Patent 2 520 733
Mukai T, Asasaka T, Sato E, Mori K, Matsumoto M, Ohori H (2002)
Inhibition of binding of Helicobacter pylori to the glycolipid
receptors by probiotic Lactobacillus reuteri. FEMS Immunol
Med Microbiol 32:105–110
Nagasawa T, Nakamura T, Yamada H (1990) Production of acrylic
acid and methacrylic acid using Rhodococcus rhodochrous J1
nitrilase. Appl Microbiol Biotechnol 34:322–324
Narayanasamy K, Shukla S, Parekh LJ (1990) Utilization of
acrylonitrile by bacteria isolated from petrochemical waste
waters. Indian J Exp Biol 28:968–971
Nawaz MS, Franklin W, Cerniglia CE (1993) Degradation of
acrylamide by immobilized cells of a Pseudomonas sp. and
Xanthomonas maltophilia. Can J Microbiol 39:207–212
Nawaz MS, Franklin W, Cerniglia CE (1994) Degradation of
aliphatic amide mixture by immobilized and nonimmobilized
cells of Pseudomonas sp. Environ Sci Technol 28:1106–1109
Nef JU (1904) Dissociationsvorgänge in der Glycol-Glycerinreihe.
Ann Chem 335:191–245
Nielsen AT, Moore DW, Schuetze Jr (1981) A 13C and 1H NMR
study of formaldehyde reactions with acetaldehyde and acro-
lein. Synthesis of 2-(hydroxymethyl)-1,3-propanediol. Pol J
Chem 55:1393–1403
Noble A (1999) Why do wines taste bitter and feel astringent? In:
Waterhouse AL, Ebeler SE (eds) Chemistry of wine flavor. Am
Chem Soc, Washington, D.C., pp 156–165
O’Loughlin, Bowmer KH (1975) Dilution and decay of aquatic
herbicides in flowing channels. J Hydrol 26:217–235
Otsuka K (2003) Studies on the mechanism of glycerol metabolism
by microbes. Bull Res Inst Ferment Yamanashi Univ 5:1–58
Pasteur L (1858a) Nouvelles recherches sur la fermentation
alcoolique. C R Acad Sci XLVII:224
Pasteur L (1858b) Production constante de glycérine dans la
fermentation alcoolique. C R Acad Sci XLVI:857
Pasteur L (1866) Etudes sur le vin, ses maladies; causes qui les
provoquent, procédées nouveaux pour le conserver et pour le
vieillir. Masson, Paris
Pressman D, Lucas HJ (1942) Hydration of unsaturated compounds.
XI. Acrolein and acrylic acid. J Am Chem Soc 64:1953–1957
Rasch M (2002) The influence of temperature, salt and pH on the
inhibitory effect of reuterin on Escherichia coli. Int J Food
Microbiol 72:225–231
Read RR (2002) β-Hydroxypropionic acid. Org Synth 1:321
Redtenbacher J (1843) Über die Zerlegungsprodukte des Glycer-
inoxydes durch trockene Destillation. Ann Chem Pharm
47:113–148
Redtenbacher J (1846) Über eine neue Entstehungsweise der
Metacetonsäure. Ann Chem Pharm 57:170
Reid G (1999) The scientific basis for probiotic strains of
Lactobacillus. Appl Environ Microbiol 65:3763–3766
Rentschler H, Tanner H (1951) Das Bitterwerden der Rotweine. Mitt
Lebensm-Unters Hyg 42:463–475
26
Reymolds H, Hoehn WM, Werkman CH (1939) Occurrence of
acrolein as an intermediate during the fermentation of glycerol
by the coli-aerogenes bacteria. Iowa State Coll J Sci 13:277
Sauvageot N, Gouffi K, Laplace JM, Auffray Y (2000) Glycerol
metabolism in Lactobacillus collinoides: production of 3-
hydroxypropionaldehyde, a precursor of acrolein. Int J Food
Microbiol 55:167–170
Schauenstein E, Esterbauer H, Zollner H (1977) Saturated
aldehydes. In: Schauenstein E, Esterbauer H, Zollner H (eds)
Aldehydes in biological systems their natural occurrence and
biological activities. Pion, London, pp 9–24
Scheele CW (1931) On the peculiar saccharine principle in
expressed oils and fats. The collected papers of CW Scheele
255–258
Schoenberger CR (2003) Greenhouse effect. Forbes Magazine
(http://www.forbes.com/forbes/2003/0203/054_print.html)
Schütz H, Radler F (1984) Anaerobic reduction of glycerol to
propanediol-1.3 by Lactobacillus brevis and Lactobacillus
buchneri. Syst Appl Microbiol 5:169–178
Serjak WC, Day WH, Van Lanen JM, Boruff CS (1954) Acrolein
production by bacteria found in distillery grain mashes. Appl
Microbiol 2:14–20
Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T
(1997) Lactobacillus reuteri as a therapeutic agent in acute
diarrhea in young children. J Pediatr Gastroenterol Nutr
24:399–404
Slininger PJ, Bothast RJ (1985) Optimizing aerobic conversion of
glycerol to 3-hydroxypropionaldehyde. Appl Environ Micro-
biol 50:1444–1450
Slininger PJ, Bothast RJ, Smiley KL (1983) Production of 3-
hydroxypropionaldehyde from glycerol. Appl Environ Micro-
biol 46:62–67
Smiley KL, Sobolov M (1962) A cobamide-requiring glycerol
dehydrase from an acrolein-forming Lactobacillus. Arch
Biochem Biophys 97:538–543
Sobolov M, Smiley KL (1960) Metabolism of glycerol by an
acrolein-forming Lactobacillus. J Bacteriol 79:261–266
Sponholz W-R (1993) Wine spoilage by microorganisms. In: Fleet
GH (ed) Wine microbiology and biotechnology. Harwood,
Chur, pp 395–420
Stepanow A, Schtschukin M (1927) Über die Aldolkondensation
von Formaldehyde und Acetaldehyde. Chem Zentralbl D 1167
Sung HW, Chen CN, Chang Y, Liang HF (2002) Biocompatibility
study of biological tissues fixed by a natural compound
(reuterin) produced by Lactobacillus reuteri. Biomaterials
23:3203–3214
Sung HW, Chen CN, Liang HF, Hong MH (2003) A natural
compound (reuterin) produced by Lactobacillus reuteri for
biological-tissue fixation. Biomaterials 24:1335–1347
Talarico TL, Dobrogosz WJ (1989) Chemical characterization of an
antimicrobial substance produced by Lactobacillus reuteri.
Antimicrob Agents Chemother 33:674–679
Talarico TL, Casas IA, Chung TC, Dobrogosz WJ (1988)
Production and isolation of reuterin, a growth inhibitor
produced by Lactobacillus reuteri. Antimicrob Agents Che-
mother 32:1854–1858
Tannock GW (1999) Probiotics: a critical review. Horizon,
Wymondham
Thiman KV (1955) The life of bacteria their growth, metabolism,
and relationships. MacMillan, New York
Toba T, Samant SK, Yoshioka E, Itoh T (1991) Reutericin-6, a new
bacteriocin produced by Lactobacillus reuteri La-6. Lett Appl
Microbiol 13:281–286
Toraya T (2000) Radical catalysis of B12 enzymes: structure,
mechanism, inactivation, and reactivation of diol and glycerol
dehydratases. Cell Mol Life Sci 57:106–127
Ulmer C, Deckwer W-D, Zeng A-P (2002) Zweistufiger Prozess zur
Herstellung von 1,3-Propandiol und 3-Hydroxypropionalde-
hyde aus Glycerin. Chem Ing Tech 74:674
Valerius G, Zhu X, Hofmann H, Arntz D, Haas T (1996) Modelling
of a trickle-bed reactor 2. The hydrogenation of 3-hydro-
xypropanal to 1,3-propanediol. Chem Eng Proc 35:11–19
Valeur N, Engel P, Ladefoged K (2002) Immunomodulation in the
human GI tract by the probiotic Lactobacillus reuteri (ATCC
55730/SD2112). Am J Gastroent 97:S76
Vancauwenberge JE, Slininger PJ, Bothast RJ (1990) Bacterial
conversion of glycerol to beta-hydroxypropionaldehyde. Appl
Environ Microbiol 56:329–332
Voisenet ME (1910) Formation d’acroléine dans la maladie de
l’amertume des vins. C R Acad Sci 150:1614–1616
Voisenet ME (1914a) Sur un ferment, contenu dans les eaux, agent
de déshydratation de la glycérine. C R Acad Sci 158:195–197
Voisenet ME (1914b) Sur un ferment, contenu dans les eaux, agent
de déshydratation de la glycérine. Ann Inst Pasteur 28:807–818
Vollenweider S, Grassi G, König I, Puhan Z (2003) Purification and
structural characterization of 3-hydroxypropionaldehyde and its
derivatives. J Agric Food Chem 51:3287–3293
WHO (1992) Acrolein. Environ Health Crit 127
Widmer A, Müller A (2003) Glycerin überschwemmt Europa. Chem
Rundschau 10:4–6
Wittlich P (2001) Biotechnische Herstellung von 1,3-Propandiol aus
Glycerin mit immobilisierten Zellen von Clostridium butyricum
NRRL B-1024 und thermophilen Mikroorganismen. Disserta-
tion, Technische Universität Braunschweig, Germany
Wolf BW, Garleb KA, Ataya DG, Casas IA (1995) Safety and
tolerance of Lactobacillus reuteri in healthy adult male
subjects. Microb Ecol Health Dis 8:41–50
Wolf BW, Wheeler KB, Ataya DG, Garleb KA (1998) Safety and
tolerance of Lactobacillus reuteri supplementation to a popu-
lation infected with the human immunodeficiency virus. Food
Chem Toxicol 36:1085–1094
WSSA (1983) Herbicide Handbook of the Weed Science Society of
America
Yunmbam MK, Roberts JF (1992) The in vitro efficacy of reuterin
on the culture and bloodstream forms of Trypanosoma brucei
brucei. Comp Biochem Physiol C 101:235–238
Yunmbam MK, Roberts JF (1993) In vivo evaluation of reuterin and
its combinations with suramin, melarsoprol, DL-alpha-difluor-
omethylornithine and bleomycin in mice infected with Try-
panosoma brucei brucei. Comp Biochem Physiol C 105:521–
524
Zeng AP, Biebl H (2002) Bulk chemicals from biotechnology: the
case of 1,3-propanediol production and the new trends. Adv
Biochem Eng Biotechnol 74:239–259
27
